A dministration of supplementary O 2 is considered to be safe, as exemplified by one editorial comment 1 : "Oxygen should be used as soon as possible, in as near 100% as possible in all resuscitation situations, and for the early management of injury and illness. Its use will never disadvantage [our emphasis] a patient under these circumstances." We believe this claim merits examination.
The rationale for administering O 2 is that it increases the O 2 content of blood and, therefore, O 2 delivery to tissues. In a healthy person, hemoglobin is nearly saturated, and switching from air to pure O 2 at sea level will increase O 2 content by Ͻ 10% due almost exclusively to the increase in O 2 dissolved in the plasma. In these people, the more influential determinant of O 2 delivery is tissue perfusion that is determined by perfusion pressure and local tissue vascular resistance. Vascular resistances in the brain, heart, and placenta are affected by the Pco 2 in arterial blood.
At issue is the existence of a strong link between hyperoxia and arterial Pco 2 . Oxygen has long been known, but seldom recognized, to be a respiratory stimulant resulting in hypocapnia in adults 2-6 and infants, 7-9 a result confirmed by more recent work. 10 While oxygen may not have this effect in patients with a limited ability to increase ventilation because of disease, 11 it can be expected to cause at least some hyperventilation in the vast majority of patients. This raises the possibility that hyperoxia-induced hypocapnia would cause vasoconstriction of CO 2 -resposive vascular beds and paradoxically exacerbate ischemia there, if present. Furthermore, the hypocapnia increases the affinity of hemoglobin for O 2 , reducing O 2 unloading to tissues. These effects are known from basic physiologic principles but are seldom emphasized in clinical texts or taken into account when O 2 administration is prescribed.
The link between hyperoxia and hyperventilation can be explained by the Haldane effect. Oxygenated hemoglobin binds less CO 2 (the Haldane effect); therefore, CO 2 transport must be maintained by increases in bicarbonate and dissolved CO 2 , the latter increasing local tissue Pco 2 . In most tissues, this is of no consequence; but in the brainstem, the location of the central chemoreceptors responsible for most of the respiratory drive, 12 
CO Poisoning
Pure O 2 is the recommended acute treatment for CO poisoning. However, Takeuchi and colleagues 25 demonstrated that CO-exposed subjects breathing pure O 2 hyperventilate, decreasing end-tidal Pco 2 by an average of 2.8 mm Hg, a reduction that would, in the absence of any effect of CO on cerebrovascular resistance, decrease cerebral blood flow (CBF) by approximately 7% 26 in adults and 30% in infants. 27, 28 A follow-up study 29 from the same laboratory showed that hyperoxia did reduce CBF and thereby cerebral O 2 delivery in CO-exposed subjects. This raises questions about the current recommended therapy, normobaric hyperoxia, for CO poisoning. Hyperbaric hyperoxia also decreases Pco 2 and CBF, 30 -32 an effect to which the hyperoxia contributes. 33 This reduction in CBF has not been taken into account when assessing the efficacy of hyperbaric O 2 in treating CO poisoning. The risk of viewing O 2 treatment as benign (ie, "it can't hurt") may result in ignoring its potential contribution to morbidity and attributing all adverse sequelae to CO alone.
Stroke
Hyperoxia, but not hyperventilation, 34,35 continues to be advocated for treatment of strokes 36 but no consideration has been given to the effects of hyperoxia-induced hypocapnia. As discussed above with respect to CO poisoning, any hypocapnia-induced decrease in CBF could offset any increase in blood O 2 content and reduce actual O 2 delivery. To our knowledge, there have been no studies in man of the effects of CO 2 on the efficacy of hyperoxia in the management of stroke. However, animal studies 37 suggest that hypercapnia better preserves cerebral oxidative metabolism and reduces the extent of postischemic atrophy.
Myocardial Ischemia
Breathing 100% O 2 impairs left ventricular relaxation, increases end-diastolic pressure, and decreases coronary sinus blood flow in subjects with either heart failure or normal left ventricular function. 38 No measurements were made of Pco 2 , so it is premature to attribute these effects to hypocapnia. Nevertheless, because arterial Pco 2 affects the resistance of coronary vessels, there may be little benefit, but considerable risk, in treating myocardial ischemia with hyperoxia without measures to prevent hypocapnia. In patients with congestive heart failure, hypocapnia may explain the detrimental effects of hyperoxia on some cardiovascular parameters. 11
Wound Healing
In 2000, Greif and colleagues 39 described an approximate 50% reduction in the incidence of postoperative infection in patients administered 80% O 2 during and for 2 h after an operation vs those receiving 30% O 2 . Tissue and wound Po 2 , however, depend not just on the inspired concentration of O 2 but also on perfusion; this, in turn, is affected by the arterial Pco 2 . In humans, "the skin blood flow measured on the chest decreased by an average of 8% during hyperventilation; blood flow on the hand (thenar eminence) decreased by 60%; and blood flow on the foot decreased by 51%." 40 In contrast, hypercapnia increased tissue Po 2 . This raises the question, would maintenance of normocapnia, or even slight hypercapnia, reduce wound infections or improve perfusion to ischemic chronic leg ulcers in diabetics? Hyperbaric O 2 is a useful form of treatment for chronic infections and leg ulcers, 41-44 but availability and cost limit its use 45 and are likely to do so even more as the numbers of such patients increase. For the reasons given above, preventing a fall in Pco 2 when breathing O 2 , whether normobaric or hyperbaric, may increase perfusion and thereby, one hopes, aid in tissue healing. 
Conclusion
Supplementary O 2 is typically administered without knowledge of its effect on CO 2 levels. Even when CO 2 levels can be monitored, physicians are concerned, perhaps unnecessarily, 46 -48 about hypercapnia and do not consider the potentially detrimental effects of hypocapnia. Moreover, simple breathing circuits to control Pco 2 during O 2 administration, such as those introduced by Severinghaus and colleagues 49 and Banzett and colleagues, 50 could be adapted to clinical use. The next challenge is to determine whether maintaining normocapnia, or even slight hypercapnia, during the many clinical situations in which O 2 is administered to relieve hypoxia in CO 2 -responsive vascular beds confers additional benefits and improves clinical outcomes. 
